Targeted temperature management in neurological intensive care unit

Area of Science:

• Neurology
• Critical Care Medicine

Background:

• Hypoxic/ischemic encephalopathy (HIE) and elevated intracranial pressure (ICP) are critical conditions in neurological intensive care units (ICUs).
• Cardiac arrest is a primary cause of HIE.
• While TTM's benefit for ICP in traumatic brain injury is debated, its efficacy is supported by research.

Purpose of the Study:

• To review the neuroprotective and ICP-lowering effects of Targeted Temperature Management (TTM).
• To highlight TTM's application in neurological intensive care settings.

Main Methods:

• Review of randomized control trials and in vivo/in vitro studies on TTM.
• Analysis of TTM's application in various clinical conditions.

Main Results:

• TTM demonstrates significant neuroprotective effects against HIE, especially post-cardiac arrest.
• TTM is effective in managing elevated ICP, with confirmed efficacy in research studies.
• Various TTM methods are available for clinical application.

Conclusions:

• Targeted temperature management is a key neuroprotective therapy for HIE and a viable option for ICP control in neurological ICUs.
• TTM is applicable to a range of conditions involving hypoxic/ischemic brain injury and elevated ICP.